The use of Zymosan A and bacteria anchored to tumor cells for effective cancer immunotherapy: B16-F10 murine melanoma model |
| |
| Affiliation: | 1. Department of Medical Biology, Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic;2. Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, v.v.i., České Budějovice, Czech Republic;3. Institute of Analytical Chemistry of the Czech Academy of Sciences, v.v.i., Brno, Czech Republic;1. Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, United States;2. Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States;1. Department of Experimental Medicine, Section of Microbiology and Clinical Microbiology, Faculty of Medicine and Surgery, Second University of Naples, Via Santa Maria di Costantinopoli, 16, 80138 Naples, Italy;2. Department of Biochemistry, Biophysics and General Pathology, Faculty of Medicine and Surgery, Second University of Naples, Via Santa Maria di Costantinopoli, 16, 80138 Naples, Italy;3. Department of Clinical Pathology, A. Cardarelli Hospital, Via Antonio Cardarelli, 9, 80133 Naples, Italy |
| |
| Abstract: | The idea of using killed microorganisms or their parts for a stimulation of immunity in the cancer immunotherapy is very old, but the question of interactions and binding of these preparations to tumor cells has not been addressed so far. The attachment of Zymosan A and both Gram-positive and Gram-negative bacteria to tumor cells was tested in in vivo experiments. This binding was accomplished by charge interactions, anchoring based on hydrophobic chains and covalent bonds and proved to be crucial for a strong immunotherapeutic effect. The establishment of conditions for simultaneous stimulation of both Toll-like and phagocytic receptors led to very strong synergy. It resulted in tumor shrinkage and its temporary or permanent elimination. The role of neutrophils in cancer immunotherapy was demonstrated and the mechanism of their action (frustrated phagocytosis) was proposed. Finally, therapeutic approaches applicable for safe human cancer immunotherapy are discussed. Heat killed Mycobacterium tuberculosis covalently attached to tumor cells seems to be promising tool for this therapy. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
